The global cancer biomarker testing market was valued at USD 10.42 billion in 2021 and is anticipated to grow at USD 20.59 billion by 2028 recording a CAGR of 12.4% during the forecast period 2022-2028.The capacity to identify appropriate patients for treatment based on molecular biomarkers propelled the targeted therapy oncology market to new heights. Breast cancer, gastric cancer, colorectal...
0 Commentarios
0 Acciones
1621 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian